ArticleJournal of synchrotron radiation2026
Synchrotron-based multi-scale biological imaging inside biocontainment environments.
Article in Journal of synchrotron radiation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Orion project is designed to be a state-of-the-art research complex that studies dangerous pathogens, located at the Brazilian Center for Research in Energy and Materials (CNPEM), in Campinas, Brazil. Orion is set to host the first Latin America Biosafety Level 4 (BSL-4) laboratory, designed for maximum biological containment. This facility will be integrated with the Brazilian synchrotron light source, SIRIUS, and will also feature Biosafety Level 2 (BSL-2) and 3 (BSL-3) laboratories equipped for biological research, as well as an advanced electron microscopy facility. Orion's infrastructure is poised to significantly advance the understanding of pathogens and the diseases they cause while also contributing to public health surveillance and policy development. At the core of this effort are three synchrotron-based beamlines that will connect SIRIUS to Orion, enabling cutting-edge multi-scale biological imaging. These beamlines are strategically designed to provide different levels of field-of-view, penetration power and resolutions: (1) SIBIPIRUNA, dedicated to cryo-nanotomography using soft X-ray absorption contrast for cellular imaging; (2) TIMBÓ, mainly focused on cryo-nanotomography through coherent X-ray phase-contrast for tissue studies; and (3) HIBISCO, devoted to small living animal imaging using hard X-ray phase-contrast microtomography. This unique interplay between synchrotron-based imaging techniques within biocontainment areas will undoubtedly enhance pathogen research and bioimaging, driving scientific advancements with far-reaching implications for global health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.